- Home
- LIPO vs YCBD Comparison
LIPO vs YCBD Comparison
Compare LIPO & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIPO
- YCBD
- Stock Information
- Founded
- LIPO 2005
- YCBD 2015
- Country
- LIPO United States
- YCBD United States
- Employees
- LIPO N/A
- YCBD N/A
- Industry
- LIPO Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- LIPO Health Care
- YCBD Health Care
- Exchange
- LIPO Nasdaq
- YCBD Nasdaq
- Market Cap
- LIPO 3.1M
- YCBD 3.2M
- IPO Year
- LIPO 2022
- YCBD N/A
- Fundamental
- Price
- LIPO $2.57
- YCBD $0.33
- Analyst Decision
- LIPO Strong Buy
- YCBD
- Analyst Count
- LIPO 1
- YCBD 0
- Target Price
- LIPO $16.00
- YCBD N/A
- AVG Volume (30 Days)
- LIPO 45.5K
- YCBD 345.1K
- Earning Date
- LIPO 05-08-2025
- YCBD 05-14-2025
- Dividend Yield
- LIPO N/A
- YCBD N/A
- EPS Growth
- LIPO N/A
- YCBD N/A
- EPS
- LIPO N/A
- YCBD N/A
- Revenue
- LIPO $536,357.00
- YCBD $19,220,238.00
- Revenue This Year
- LIPO N/A
- YCBD $13.00
- Revenue Next Year
- LIPO N/A
- YCBD $10.00
- P/E Ratio
- LIPO N/A
- YCBD N/A
- Revenue Growth
- LIPO 19.29
- YCBD N/A
- 52 Week Low
- LIPO $2.02
- YCBD $0.22
- 52 Week High
- LIPO $12.00
- YCBD $1.25
- Technical
- Relative Strength Index (RSI)
- LIPO 48.43
- YCBD 52.13
- Support Level
- LIPO $2.13
- YCBD $0.21
- Resistance Level
- LIPO $2.74
- YCBD $0.28
- Average True Range (ATR)
- LIPO 0.21
- YCBD 0.04
- MACD
- LIPO 0.05
- YCBD 0.01
- Stochastic Oscillator
- LIPO 76.06
- YCBD 58.57
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.